ATE358673T1 - Nf-kb-inhibitoren - Google Patents
Nf-kb-inhibitorenInfo
- Publication number
- ATE358673T1 ATE358673T1 AT03731435T AT03731435T ATE358673T1 AT E358673 T1 ATE358673 T1 AT E358673T1 AT 03731435 T AT03731435 T AT 03731435T AT 03731435 T AT03731435 T AT 03731435T AT E358673 T1 ATE358673 T1 AT E358673T1
- Authority
- AT
- Austria
- Prior art keywords
- kappab
- inhibitors
- diseases
- activation
- aminothiophene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38655702P | 2002-06-06 | 2002-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE358673T1 true ATE358673T1 (de) | 2007-04-15 |
Family
ID=29736178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03731435T ATE358673T1 (de) | 2002-06-06 | 2003-05-29 | Nf-kb-inhibitoren |
Country Status (8)
Country | Link |
---|---|
US (1) | US7300952B2 (de) |
EP (1) | EP1532135B1 (de) |
JP (1) | JP2005532359A (de) |
AT (1) | ATE358673T1 (de) |
AU (1) | AU2003240935A1 (de) |
DE (1) | DE60312997T2 (de) |
ES (1) | ES2285125T3 (de) |
WO (1) | WO2003104219A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7199119B2 (en) | 2002-10-31 | 2007-04-03 | Amgen Inc. | Antiinflammation agents |
US7696244B2 (en) | 2003-05-16 | 2010-04-13 | The Regents Of The University Of California | Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof |
MXPA06012682A (es) * | 2004-05-04 | 2007-01-16 | Hoffmann La Roche | Tienopiridinas como inhibidores ikk. |
MXPA06012684A (es) * | 2004-05-04 | 2007-01-16 | Hoffmann La Roche | Tienopiridazinas como inhibidores ikk. |
US7812018B2 (en) | 2006-02-16 | 2010-10-12 | Millennium Pharmaceuticals, Inc. | Alpha carbolines and uses thereof |
WO2008069102A1 (ja) * | 2006-12-06 | 2008-06-12 | Calpis Co., Ltd. | 炎症性腸疾患予防治療剤 |
US8299055B2 (en) | 2008-10-02 | 2012-10-30 | Asahi Kasei Pharma Corporation | 8-substituted isoquinoline derivative and the use thereof |
WO2013118842A1 (ja) * | 2012-02-09 | 2013-08-15 | 国立大学法人東京医科歯科大学 | ベンゾチオフェン化合物、該化合物を有効成分とするオルタナティブオートファジー誘導剤及び抗癌剤、並びに抗癌活性を有する化合物をスクリーニングするための方法 |
EP3194366A1 (de) * | 2014-09-15 | 2017-07-26 | Ecole Polytechnique Fédérale de Lausanne (EPFL) | Benzothiophen-, benzyloxybenzyliden- und indolinderivate zur behandlung von tuberkulose |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4782080A (en) * | 1985-09-16 | 1988-11-01 | Merck & Co., Inc. | N-alkenyl-2-hydroxybenzo(b)thiophene-3-carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors |
US6545027B1 (en) | 1995-06-07 | 2003-04-08 | Eli Lilly And Company | Methods of modulating NF-kB transcription factor |
WO1998048793A1 (en) * | 1997-04-30 | 1998-11-05 | Eli Lilly And Company | INTERMEDIATES AND PROCESSES FOR PREPARING BENZO[b]THIOPHENES |
JP2004523476A (ja) * | 2000-10-12 | 2004-08-05 | スミスクライン・ビーチャム・コーポレイション | NF−κB阻害剤 |
-
2003
- 2003-05-29 EP EP03731435A patent/EP1532135B1/de not_active Expired - Lifetime
- 2003-05-29 WO PCT/US2003/016876 patent/WO2003104219A1/en active IP Right Grant
- 2003-05-29 AU AU2003240935A patent/AU2003240935A1/en not_active Abandoned
- 2003-05-29 AT AT03731435T patent/ATE358673T1/de not_active IP Right Cessation
- 2003-05-29 JP JP2004511289A patent/JP2005532359A/ja not_active Withdrawn
- 2003-05-29 DE DE60312997T patent/DE60312997T2/de not_active Expired - Fee Related
- 2003-05-29 ES ES03731435T patent/ES2285125T3/es not_active Expired - Lifetime
- 2003-05-29 US US10/517,111 patent/US7300952B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2285125T3 (es) | 2007-11-16 |
US7300952B2 (en) | 2007-11-27 |
WO2003104219A1 (en) | 2003-12-18 |
EP1532135A4 (de) | 2005-11-09 |
US20060058371A1 (en) | 2006-03-16 |
DE60312997T2 (de) | 2007-12-13 |
AU2003240935A1 (en) | 2003-12-22 |
DE60312997D1 (de) | 2007-05-16 |
EP1532135A1 (de) | 2005-05-25 |
JP2005532359A (ja) | 2005-10-27 |
EP1532135B1 (de) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE414697T1 (de) | Nf-kb-inhibitoren | |
NO20061197L (no) | Proteasominhibitorer og fremgangsmater for anvendelse av samme | |
ATE387194T1 (de) | Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung | |
SE0203752D0 (sv) | New compounds | |
MA28176A1 (fr) | Inhibiteurs de la forme mutante du kit | |
ATE396731T1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
IS8913A (is) | Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk | |
ATE418336T1 (de) | Verwendung von i kappa b-kinase inhibitoren in der schmerztherapie | |
DE50306850D1 (de) | Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen | |
ATE423087T1 (de) | Proteasome inhibitoren und deren verwendung | |
ATE358673T1 (de) | Nf-kb-inhibitoren | |
ATE382048T1 (de) | Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen | |
DE60322898D1 (de) | Verwendung von isoflavonen zur förderung des schlankheitseffekts | |
TW200508233A (en) | Chk-1 inhibitors | |
DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
MY162518A (en) | Proteasome inhibitors and methods of using the same | |
ATE534380T1 (de) | Glepp-1-hemmer bei der behandlung von autoimmun- und/oder entzündungskrankheiten | |
DE60329326D1 (de) | Tace inhibitoren | |
WO2003086309A3 (en) | NF-κB INHIBITORS | |
ATE536874T1 (de) | Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen | |
ATE376416T1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen | |
DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
ATE438859T1 (de) | Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz | |
ATE548040T1 (de) | Verwendung von vasopeptidase-inhibitoren zur behandlung von nephropathie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |